These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 28228557

  • 1. Surfactant Protein A Inhibits Growth and Adherence of Uropathogenic Escherichia coli To Protect the Bladder from Infection.
    Hashimoto J, Takahashi M, Saito A, Murata M, Kurimura Y, Nishitani C, Takamiya R, Uehara Y, Hasegawa Y, Hiyama Y, Sawada N, Takahashi S, Masumori N, Kuroki Y, Ariki S.
    J Immunol; 2017 Apr 01; 198(7):2898-2905. PubMed ID: 28228557
    [Abstract] [Full Text] [Related]

  • 2. Surfactant protein D inhibits adherence of uropathogenic Escherichia coli to the bladder epithelial cells and the bacterium-induced cytotoxicity: a possible function in urinary tract.
    Kurimura Y, Nishitani C, Ariki S, Saito A, Hasegawa Y, Takahashi M, Hashimoto J, Takahashi S, Tsukamoto T, Kuroki Y.
    J Biol Chem; 2012 Nov 16; 287(47):39578-88. PubMed ID: 23012359
    [Abstract] [Full Text] [Related]

  • 3. Group 3 Innate Lymphoid Cells Protect the Host from the Uropathogenic Escherichia coli Infection in the Bladder.
    Huang J, Fu L, Huang J, Zhao J, Zhang X, Wang W, Liu Y, Sun B, Qiu J, Hu X, Liu Z, Guo X.
    Adv Sci (Weinh); 2022 Feb 16; 9(6):e2103303. PubMed ID: 35018740
    [Abstract] [Full Text] [Related]

  • 4. Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection.
    Lin AE, Beasley FC, Olson J, Keller N, Shalwitz RA, Hannan TJ, Hultgren SJ, Nizet V.
    PLoS Pathog; 2015 Apr 16; 11(4):e1004818. PubMed ID: 25927232
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
    Bokil NJ, Totsika M, Carey AJ, Stacey KJ, Hancock V, Saunders BM, Ravasi T, Ulett GC, Schembri MA, Sweet MJ.
    Immunobiology; 2011 Nov 16; 216(11):1164-71. PubMed ID: 21802164
    [Abstract] [Full Text] [Related]

  • 7. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli.
    Billips BK, Forrestal SG, Rycyk MT, Johnson JR, Klumpp DJ, Schaeffer AJ.
    Infect Immun; 2007 Nov 16; 75(11):5353-60. PubMed ID: 17724068
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dual ligand/receptor interactions activate urothelial defenses against uropathogenic E. coli.
    Liu Y, Mémet S, Saban R, Kong X, Aprikian P, Sokurenko E, Sun TT, Wu XR.
    Sci Rep; 2015 Nov 09; 5():16234. PubMed ID: 26549759
    [Abstract] [Full Text] [Related]

  • 10. Augmentation of Urinary Lactoferrin Enhances Host Innate Immune Clearance of Uropathogenic Escherichia coli.
    Patras KA, Ha AD, Rooholfada E, Olson J, Ramachandra Rao SP, Lin AE, Nizet V.
    J Innate Immun; 2019 Nov 09; 11(6):481-495. PubMed ID: 31055580
    [Abstract] [Full Text] [Related]

  • 11. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding.
    Zhou G, Mo WJ, Sebbel P, Min G, Neubert TA, Glockshuber R, Wu XR, Sun TT, Kong XP.
    J Cell Sci; 2001 Nov 09; 114(Pt 22):4095-103. PubMed ID: 11739641
    [Abstract] [Full Text] [Related]

  • 12. Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection.
    Duell BL, Carey AJ, Tan CK, Cui X, Webb RI, Totsika M, Schembri MA, Derrington P, Irving-Rodgers H, Brooks AJ, Cripps AW, Crowley M, Ulett GC.
    J Immunol; 2012 Jan 15; 188(2):781-92. PubMed ID: 22184725
    [Abstract] [Full Text] [Related]

  • 13. Uropathogenic Escherichia coli Engages CD14-Dependent Signaling to Enable Bladder-Macrophage-Dependent Control of Acute Urinary Tract Infection.
    Carey AJ, Sullivan MJ, Duell BL, Crossman DK, Chattopadhyay D, Brooks AJ, Tan CK, Crowley M, Sweet MJ, Schembri MA, Ulett GC.
    J Infect Dis; 2016 Feb 15; 213(4):659-68. PubMed ID: 26324782
    [Abstract] [Full Text] [Related]

  • 14. Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M, Asadi Karam MR, Bouzari S.
    APMIS; 2016 Jun 15; 124(6):444-52. PubMed ID: 26918627
    [Abstract] [Full Text] [Related]

  • 15. A non-canonical autophagy-dependent role of the ATG16L1T300A variant in urothelial vesicular trafficking and uropathogenic Escherichia coli persistence.
    Wang C, Bauckman KA, Ross ASB, Symington JW, Ligon MM, Scholtes G, Kumar A, Chang HW, Twentyman J, Fashemi BE, Xavier RJ, Mysorekar IU.
    Autophagy; 2019 Mar 15; 15(3):527-542. PubMed ID: 30335568
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Innate immunity of surfactant proteins A and D in urinary tract infection with uropathogenic Escherichia coli.
    Hu F, Ding G, Zhang Z, Gatto LA, Hawgood S, Poulain FR, Cooney RN, Wang G.
    Innate Immun; 2016 Jan 15; 22(1):9-20. PubMed ID: 26511057
    [Abstract] [Full Text] [Related]

  • 19. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M, Asadi Karam MR, Shokrgozar MA, Oloomi M, Jafari A, Bouzari S.
    Mol Immunol; 2015 Apr 15; 64(2):285-94. PubMed ID: 25562574
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.